BXP, Inc.
NYSE:BXPREIT - Office
-$2.67 today
- Market cap
- $10.20B
- Beta
- 1.06
- P/E (TTM)
- 31.5
- EPS (TTM)
- $2.00
- Dividend yield
- 4.88%
Volume 1.12M
Average 1.75M
BXP Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
BXP, Inc.NYSE: BXP
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 23.8% from a year ago
Cash & equivalents stood at $553.46M at the end of Q2 FY2026, up 23.8% from a year earlier and up 7.9% from the prior quarter. Over 3 fiscal years it compounded at +28.9% a year.
Context
- Cash & equivalents amounted to 2.2% of total assets at the end of Q2 FY2026, up 0.5 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +23.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 1.48B USD
- Year-over-year change
- +17.8%
- 4-year CAGR
- +34.4%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.48B | +17.8% |
| FY2024 | 2024-12-31 | 1.25B | -18.1% |
| FY2023 | 2023-12-31 | 1.53B | +121.8% |
| FY2022 | 2022-12-31 | 690.33M | +52.5% |
| FY2021 | 2021-12-31 | 452.69M | — |
Cash & Equivalents vs competitors
How BXP compares with its peers on the latest reported figures
- BXP's Jun 2026 cash & equivalents of $553.46M is the highest of the 10 companies compared; the peer median is $70.61M.
- Its year-over-year change of +23.8% is the 5th highest of 10, against a peer median of +13.5%.
- Cash & equivalents amounts to 2.2% of total assets for BXP, versus a peer median of 2.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $553.46M | +23.8% | +28.9% | 2.2% | |
| Sep 2026 | $385.95M | +2165.1% | +18.3% | 3.3% | |
| Mar 2026 | $162.44M | +87.8% | -18.5% | 2.2% | |
| Jun 2026 | $145.38M | +586.0% | +8.6% | 2.2% | |
| Sep 2026 | $94.3M | -74.7% | -19.8% | 0.8% | |
| Mar 2026 | $70.61M | +150.8% | +194.8% | 27.4% | |
| Jun 2026 | $24.16M | +13.5% | +181.4% | 0.5% | |
| Mar 2026 | $23.75M | -21.3% | +101.5% | 2.7% | |
| Jun 2026 | $6.7M | -98.4% | +3.6% | 0.1% | |
| Mar 2026 | $2.28M | -21.7% | -64.6% | 0.1% | |
| Peer median (excluding BXP) | $70.61M | +13.5% | +8.6% | 2.2% | |
Competitors are the stored peer set for BXP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 452.69M | 690.33M | 1.53B | 1.25B | 1.48B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.38B | 1.45B | 1.58B | 1.68B | 1.65B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (9.35M) | 46.48M | 81.09M | 144.05M | 249.65M |
| Total Current Assets | 1.89B | 2.19B | 3.19B | 3.08B | 3.37B |
| Property, Plant & Equipment (Net) | 0 | 404.86M | 0 | 707.69M | 20.38B |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 713.97M | 0 | 0 | 0 |
| Long-term Investments | 1.53B | 1.75B | 1.41B | 1.13B | 1.04B |
| Tax Assets | 0 | (713.97M) | 0 | 0 | 0 |
| Other Non-current Assets | 18.95B | 19.87B | 21.42B | 21.16B | 1.37B |
| Total Non-current Assets | 20.48B | 22.02B | 22.83B | 23B | 22.79B |
| Total Assets | 22.37B | 24.21B | 26.03B | 26.08B | 26.17B |
| Account Payables | 320.78M | 417.55M | 458.33M | 401.87M | 480.02M |
| Short-term Debt | 145M | 0 | 0 | 500M | 750M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 138.92M | 0 | 101.23M | 123.75M |
| Total Current Liabilities | 730.43M | 691.96M | 763.19M | 1.2B | 1.48B |
| Long-term Debt | 12.75B | 14.24B | 15.86B | 15.72B | 15.86B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 391.44M | 450.92M | 445.95M | 181.96M | 393.61M |
| Total Non-current Liabilities | 13.59B | 15.15B | 17.07B | 16.93B | 17B |
| Total Liabilities | 14.32B | 15.84B | 17.83B | 18.14B | 18.48B |
| Common Stock | 1.57M | 1.57M | 1.57M | 1.58M | 1.59M |
| Retained Earnings | (625.89M) | (391.36M) | (816.15M) | (1.42B) | 0 |
| Accumulated OCI | (36.66M) | (13.72M) | (21.15M) | 9.54M | (1.69B) |
| Other Stockholders Equity | 9.57M | 0 | 8.38M | (2.07M) | 0 |
| Minority Interest | 2.2B | 2.24B | 2.31B | 2.52B | 2.54B |
| Total Equity | 8.04B | 8.37B | 8.19B | 7.94B | 7.68B |
| Total Debt | 13.35B | 14.69B | 16.62B | 17.32B | 17.36B |
| Net Debt | 12.89B | 14B | 15.09B | 16.07B | 15.88B |
BXP, Inc.
NYSE:BXP
Intrinsic Alpha fair value
Locked
Current Price
$63.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.